Feasibility Study for the Use of Low-magnitude, High Frequency Mechanical Stimulation of Bone in Persons With Spinal Cord Injury (SCI)
NCT ID: NCT00882843
Last Updated: 2012-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
22 participants
OBSERVATIONAL
2006-09-30
2010-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Vibration Therapy on Bone in Persons With Sub-acute Spinal Cord Injury
NCT00886145
Transspinal Stimulation Plus Locomotor Training for SCI
NCT04807764
Non-invasive Cervical Electrical Stimulation for SCI
NCT03414424
Neural Facilitation of Movements in People With SCI
NCT05354206
SCI Acute Intermittent Hypoxia and Non-Invasive Spinal Stimulation Combined With Gait Training
NCT03922802
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. positional modification (sitting, lying or standing if tolerable);
2. bracing the knee to prevent flexion/extension;
3. bracing the legs above and/or below the knee;
4. supporting the ankle;
5. tilting the surface (tilt table) to a maximum angle of 45 degrees;
6. Standing with the assistance of a standing frame if subject can tolerate standing for 5 minute time periods.
7. increasing the magnitude of the plate acceleration (0.2-0.6g); and
8. mechanically pressing the legs (ankle and knee joints relatively fixed in position by an orthotic device) against the plate by a spring-loaded method (it is envisioned that a padded belt-like article will be worn around the waist and would be attached with bungee cords (or springs) to each side of the vibrating plate; the maximum force delivered would be equal to 50 lbs or one-third of total body weight, whichever is less).
An accelerometer for the measurement of impulse generation will be placed on the surface of the vibrating plate between the feet; a second will be placed on the shin about 4 inches below the knee (attached with double sided tape and athletic bandage wrap); a third accelerometer will be placed in the mouth as a bite-bar. Measurements would be acquired with combinations of body position, joint/leg fixation, magnitude of plate acceleration ("g" force), and mechanical force pressing the feet against the plate to determine the optimal transmission of impulse.
This study will determine the optimal of the methodology for using the vibrating plate to transmit an impulse in persons with chronic SCI, with the anticipation of its application to increase bone mass in individuals with acute or chronic SCI. It is anticipated that each session will be between 30 and 120 minutes. An individual may voluntarily participate in as many as 5 sessions. The knowledge gained from the first sets of studies will obviate the need to perform less effective methods of mechanical signal transmission in subsequent studies. It is anticipated that once the most effective, as well as clinically applicable, form of mechanical stimulation is identified, it will be performed in most of the subjects. This preliminary study will also provide the information required to determine practical aspects of the length of each session and number of sessions per week in a future intervention trial.
Since this research may have adverse effects on an unborn child and should not be done during pregnancy, we will administer a pregnancy test when appropriate. Subjects will be asked to avoid becoming pregnant and use contraceptives, take precautions against becoming pregnant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Healthy Able bodied Control
No interventions assigned to this group
Group 2
Spinal Cord Injury
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. 18+ years of age
Exclusion Criteria
2. Flexion contractures of the lower extremities
3. Femur or tibia fracture or history of extensive bone trauma
4. History of prior bone disease
5. Post-menopausal women
6. Renal disease (creatinine clearance \< 40 ml/min)
7. Endocrine disorders known to be associated with osteoporosis (hyperthyroidism, hypercortisolism, hypogonadism)
8. Alcoholism
9. Seizure disorders
10. All pressure ulcers of the sacral/pelvic region, lower extremities, and heels
11. Pacemakers, implanted cardiac defibrillators, or any other electrical cardiac device
12. Implanted rods placed between 2 or more vertebral segments
13. Pregnant women (pregnancy test will be administered when applicable)
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
US Department of Veterans Affairs
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Bauman, MD
Role: PRINCIPAL_INVESTIGATOR
VA Medical Center, Bronx
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Medical Center, Bronx
The Bronx, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B4162C-9
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.